FDA issued a Warning Letter to Frontida BioPharm Inc on 8/15/2016 as a result of this inspection.
483 Frontida BioPharm Jul 2015

483 Frontida BioPharm Jul 2015

Gayle Lawson FDA, Lisa Orr FDA, Sharon Thoma FDA$119.00 - Available Now

FDA investigators audited the Frontida BioPharm - Philadelphia, PA, United States facility and issued inspectional observations (via FDA 483) on 17 Jul 2015.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Jul 2015
  • Location: Philadelphia, United States
  • FEI: 2523348
Add To Cart